24/7 Wall St. - Insightful Analysis and Commentary for U.S. and Global Equity Investors

Search this site
Home
Special Reports
Rumors
The Wire
Commodities
Buffett
Oil & Gas

Your email address

terms and conditions

Hot:

Record NYSE Margin »
Sears as REIT »
InterOil and Exxon »
Vacation Homes Hot Spots »

Posts related to ‘hepatitis c drugs’

Abbott’s Hep-C Pressures All Hep-C Rivals (ABT, RIGL, GILD, VRTX, IDIX)

Posted: April 4, 2012 at 1:28 pm

News from Abbott Laboratories (NYSE: ABT) on its positive Phase II study results from two different interferon-free hepatitis C treatment has the entire drug sector up in arms as it ...
Read Full Story »

Categories:
- 24/7 Wall St. Wire (9983)
- Accounting (513)
- Active Trader (4416)
- Aerospace & Defense (230)
- Alternative Energy (1061)
- Analyst Calls (5086)
- Autos (1477)
- Banking & Finance (3796)
- Bankruptcy (283)
- Buffett (339)
- Calendar (421)
- Casinos & Hotels (99)
- Commodities & Metals (1362)
- Consumer Product (796)
- Corporate Governance (1997)
- Dividends & Buybacks (931)
- Earnings (4159)
- Economy (3711)
- Editor's Picks (516)
- ETFs & Mutual Funds (825)
- General (3838)
- Healthcare (1435)
- Housing (1043)
- Industrials (632)
- Infrastructure (605)
- International Markets (4181)
- Internet (2200)
- IPOs & Secondaries (1653)
- Jobs (158)
- Labor (657)
- Media (4210)
- Mergers & Acquisitions (2229)
- Oil & Gas (2579)
- Personal Finance (309)
- Politics (826)
- Polls (34)
- Regulation (1166)
- Retail (2592)
- Rumors (1093)
- Services (301)
- Special Report (378)
- Technology (3829)
- Telecom & Wireless (1694)
- Transportation (581)
- Value Investing (767)

Recent Posts
Get Quote for:
Symbol Lookup

Search

Home
About Us
Disclaimer and Terms of Use
Privacy Policy
Contact Us
Advertise

©2013 24/7 Wall St. | Powered by WordPress.com VIP